Celon Pharma SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celon Pharma SA with three other
pharmaceutical manufacturers in Europe:
Vistin Pharma ASA
sales of 227.19 million Norwegian Kroner [US$22.97 million]
Calliditas Therapeutics AB
(184.83 million Swedish Kronor [US$19.21 million]
of which 100%
was Operations), and
based in NORWAY
(281.56 million Norwegian Kroner [US$28.46 million]
of which 52%
was Hexvix/Cysview Own Sales).